Bayer Aktiengesellschaft

Troponwerke Gmbh & Co Kg

Bayer Aktiengeselechaft

Oswald Lockhoff

Peter Stadler

Hans-Joachim Zeiler

Karl G Metzger

Klaus Schaller

Bernd-Wieland Kruger

Klaus G Stunkel

Helmut Brunner

Hans-Georg Opitz

Yutaka Hayauchi

Elisabeth Perzborn

Arnold Paessens

Burkhard Mielke

Hein-Peter Kroll

Peter Kurka

Gert Streissle

Dieter Neuser

Eva Lesur

Johannes Peter Stasch

Uwe Petersen

Bodo Junge

Harald Horstmann

Martin Scheer

Friedrich Berschauer

Karl-Georg Metzger

Michael Sperzel

John W Goossens

Anno De Jong

Bernhard Pelster

Volker Klimetzek

Peter Taylor

The present invention relates to (2-aminoacylamino-2-deoxy-glycosyl)-amides, which are substituted on the nitrogen atom of the amino acid, of the general formula (I) ##STR1## in which the substituents have the meaning given in the description, to processes for their preparation and to their use in medicaments.

Glycosyl-amides of 2-aminoacylamino-2-deoxy-sugars

Combined preparations with vascular effect containing dihydropyridines

Glycosylamides of 2-aminoacylamino-2-deoxy sugars

Acetylsalicylic acid nitrates

The invention relates to new N-glycosylamides of the general formula I ##STR1## in which R.sup.1 denotes a saturated alkyl radical or a singly, doubly or triply unsaturated alkenyl radical having up to 50 carbon atoms,

Substituted N-glycosylamides, process for their preparation, and their

A N-glycosylamide derivative of the formula (I) ##STR1## in which R.sup.1 denotes hydrogen or a saturated or mono- or polyunsaturated alkyl radical with one to 50 carbon atoms,

N-glycosylamide derivatives, processes for their preparation and their

Compounds of the formula ##STR1## in which R.sup.1 denotes hydrogen or a saturated or singly or multiply unsaturated alkyl radical having up to 50 carbon atoms,

Novel pharmaceutically active

Compounds of the formula ##STR1## wherein R.sup.1 is hydrogen, an optionally substituted aromatic hydrocarbon radical, an aralkyl radical or an optionally substituted aliphatic hydrocarbon radical having up to 45 C atoms,

Immune system-stimulating N-glycosylated ureas and carbamates

Compounds of the formula ##STR1## in which X is hydrogen or the radical CH.sub.2 OR.sup.5,

Pharmaceutical use of substituted O-acylglycosides

A method of combating rheumatic diseases which comprises administering to a patient afflicted therewith an amount effective to combat such disease of a compound of the formula ##STR1## in which Z is a glycosyl radical bonded via the anomeric carbon atom,

N-glycosylated carboxylic acid derivatives as agents for combating

Novel compounds of the formula ##STR1## in which X is hydrogen or --CH.sub.2 --OR.sup.5,

Substituted O-sulphonyl-glycosylamides, processes for their preparation

Compounds of the formula ##STR1## in which R.sup.1 represents an optionally substituted, straight-chain or branched, saturated, monounsaturated or polyunsaturated alkyl radical, an optionally substituted, saturated or one- or polyunsaturated cycloalkyl radical or an optionally substituted aryl radical or aralkyl radical,

Phosphorylated glycosyl-amides, -ureas, -carbamates and -thiocarbamates

The invention relates to N-glycosylated carboxamide derivatives of Formula I which are useful for influencing the body's inherent defenses, e.g. for increasing immune system antibodies. Also included in the invention are compositions containing said N-glycosylated carboxamide derivative of Formula I as active ingredients and methods for the use of said compounds and compositions.

N-glycosylated carboxamide derivatives and their use for influencing the

Growth of animals is promoted by inclusion in their feed of compounds of the formula ##STR1## in which Z is a glycosyl radical bonded via the anomeric carbon atom,

N-glycosylated carboxamide derivatives as growth-promoters in livestock

Compounds of the formula ##STR1## in which R.sup.1 represents hydrogen or an optionally substituted, straight-chain or branched alkyl or mono- or poly-unsaturated alkenyl radical with in each case up to 30 C atoms,

N-acylated 1-alkylamino-1-deoxy-ketose derivatives, a process for their

Growing community of inventors

Cologne, Germany

Oswald Lockhoff